Similarly, interleukin 6 (IL-6), an inflammatory cytokine and an indicator of preterm birth and intra-amniotic inflammation [61,62], was also involved in the analyses, since IL-6 is a major player in the pathogenesis of atherosclerosis, and its blockade may reduce cardiovascular risk in high-risk populations [63]. Here, IL6 is linked to atherosclerosis.